Skip to main content

Electrochemotherapy in Treatment of Cutaneous Tumors

  • Chapter
  • 578 Accesses

Electroporation is a physical method for delivery of various molecules, such as chemothera-peutic drugs and plasmid DNA into the cells by transiently increasing permeability of the cell membrane using application of controlled external field to the cells. Electrochemotherapy is anticancer treatment that utilizes electroporation of cells to increase chemotherapeutic drug uptake, specifically at the site where electric pulses are applied. Suitable chemotherapeutic drugs for electro-chemotherapy are those with hampered transport through the plasma membrane, such as bleomycin and cisplatin. Preclinical studies have demonstrated good antitumor effectiveness of electrochemother-apy with bleomycin and cisplatin, given either intravenously or intratumorally, on different tumor and animal models. Besides antitumor effectiveness, minimal toxicity and safety of the procedure were demonstrated. Clinical studies using electrochemotherapy for treatment of cutaneous and subcutaneous tumors of different histology have demonstrated pronounced antitumor effectiveness with ~ 85% objective responses of the treated tumors. Electrochemotherapy is a new, clinically ac -knowledged method for the treatment of cutaneous and subcutaneous tumor nodules. The advantage of this therapy is its high effectiveness on tumors of different histology, simple application, minimal side effects, and the possibility of effective repetitive treatment.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Andre F, Mir LM. DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther. 2004;11(Suppl 1):S33– 42

    Article  Google Scholar 

  2. Belehradek J Jr, Orlowski S, Ramirez LH, Pron G, Poddevin B, Mir LM. Electropermeabilization of cells and tissues assessed by the quantitative and qualitative electroloading of bleomycin. Biochim Biophys Acta. 1994;1190:155– 63

    Article  CAS  PubMed  Google Scholar 

  3. Bloom DC, Goldfarb PM. The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck. Eur J Surg Oncol. 2005;31:1029– 35

    Article  CAS  PubMed  Google Scholar 

  4. Byrne CM, Thompson JF, Johnston H, Hersey P, Quinn MJ, Hughes M, McCarthy WH. Treatment of metastatic melanoma using electroporation therapy with bleomycin (elec-trochemotherapy). Melanoma Res. 2005;15:45– 51

    Article  CAS  PubMed  Google Scholar 

  5. Byrne CM, Thompson JF. Role of electrochemotherapy in the treatment of metastatic melanoma and other metastatic and primary skin tumors. Expert Rev Anticancer Ther. 2006;6:671– 8

    Article  CAS  PubMed  Google Scholar 

  6. Cemazar M, Milacic R, Miklavcic D, Dolzan V, Sersa G. Intratumoral cisplatin administration in electrochemother-apy: antitumor effectiveness, sequence dependence and platinum content. Anticancer Drugs. 1998;9:525– 30

    Article  CAS  PubMed  Google Scholar 

  7. Cemazar M, Golzio M, Sersa G, Rols MP, Teissie J. Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand? Curr Pharm Des. 2006;12:3817– 25

    Article  CAS  PubMed  Google Scholar 

  8. Cemazar M, Sersa G. Electrotransfer of therapeutic molecules into tissues. Curr Opin Mol Ther. 2007;9:554– 62

    CAS  PubMed  Google Scholar 

  9. Cemazar M, Tamzali Y, Sersa G, Tozon N, Mir LM, Miklavcic D, Lowe R, Teissie T. Electrochemotherapy in veterinary oncology. J Vet Int Med. 2008;22:826– 31

    Article  CAS  Google Scholar 

  10. Domenge C, Orlowski S, Luboinski B, De Baere T, Belehradek J Jr, Mir LM. Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer. 1996;77:956– 63

    Article  CAS  PubMed  Google Scholar 

  11. Gehl J, Skovsgaard T, Mir LM. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta. 2002; 1569:51– 8

    CAS  PubMed  Google Scholar 

  12. Gehl J, Geertsen PF. Palliation of haemorrhaging and ulcerated cutaneous tumours using electrochemotherapy. EJC Suppl. 2006;4:35– 7

    Google Scholar 

  13. Heller R, Jaroszeski MJ, Glass LF, Messina JL, Rapaport DP, DeConti R, Fenske NA, Gilbert RA, Mir LM, Reintgen DS. Phase I/II trial for treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer. 1996; 77:964– 71

    Article  CAS  PubMed  Google Scholar 

  14. Heller R, Jaroszeski M, Perrott R, Messina J, Gilbert R. Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res. 1997;7:10– 8

    Article  CAS  PubMed  Google Scholar 

  15. Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, DeConti RC, Gilbert RA, Glaas LF. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer. 1998;83:148– 57

    Article  CAS  PubMed  Google Scholar 

  16. Heller R, Gilbert R, Jaroszeski MJ. Clinical applications of electrochemotherapy. Adv Drug Deliver Rev. 1999;35:119– 29

    Article  CAS  Google Scholar 

  17. Heller LC, Heller R. In vivo electroporation for gene therapy. Hum Gene Ther. 2006;17:890– 7

    Article  CAS  PubMed  Google Scholar 

  18. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, Billard V, Geertsen PF, Larkin JO, Miklavcic D, Pavlovic I, Paulin-Kosir SM, Cemazar M, Morsli N, Soden DM, Rudolf Z, Robert C, O' Sullivan GC, Mir LM. Electrochemotherapy — an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Suppl. 2006;4:3– 13

    CAS  Google Scholar 

  19. Miklavcic D, Corovic S, Pucihar G, Pavselj N. Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy. EJC Suppl. 2006;4: 45– 51

    Google Scholar 

  20. Mir LM, Belehradek M, Domenge C, Orlowski S, Poddevin B, Belehradek J, Schwaab G, Luboinski B, Paoletti C. Electrochemotherapy, a new antitumor treatment: first clinical trial. C R Acad Sci III. 1991;313:613– 8

    CAS  PubMed  Google Scholar 

  21. Mir LM, Glass LF, Sersa G, Teissie J, Domenge C, Miklavcic D, Jaroszeski MJ, Orlowski S, Reintgen DS, Rudolf Z, Belehradek M, Gilbert R, Rols MP, Belehradek J Jr, Bachaud JM, DeConti R, Stabuc B, Cemazar M, Coninx P, Heller R. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer. 1998;77:2336– 42

    CAS  PubMed  Google Scholar 

  22. Mir LM. Bases and rationale of the electrochemotherapy. EJC Suppl. 2006;4:38– 44

    Google Scholar 

  23. Mir LM, Gehl J, Sersa G, Collins CG, Garbay JR, Billard V, Geertsen P, Rudolf Z, O' Sullivan GC, Marty. Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either sys-temically or locally and electric pulses delivered by the Cliniporator ™ by means of invasive or non-invasive electrodes. EJC Suppl. 2006;4:14– 25

    CAS  Google Scholar 

  24. Neumann E, Schaefer-Ridder M, WangY, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1982;1:841– 5

    CAS  PubMed  Google Scholar 

  25. Puc M, Corovic S, Flisar K, Petkovsek M, Nastran J, Miklavcic D. Techniques of signal generation required for electropermeabilization: survey of electropermeabilization devices. Bioelectrochem. 2004;64:113– 24

    Article  CAS  Google Scholar 

  26. Sarnaik AA, Zager JS, Sondak VK. Multidisciplinary management of special melanoma situations: oligometastatic disease and bulky nodal sites. Curr Oncol Rep. 2007; 9:417– 27

    Article  PubMed  Google Scholar 

  27. Sersa G, Miklavcic D, Cemazar M, Belehradek J Jr, Jarm T, Mir LM. Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocom-petent and immunodeficient mice. Bioelectroch Bioener. 1997;43:279– 83

    Article  CAS  Google Scholar 

  28. Sersa G, Stabuc B, Cemazar M, Jancar B, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: Potentiation of local cisplatin antitumor effectiveness by application of electric pulses in cancer patients. Eur J Cancer. 1998; 34:1213– 8

    Article  CAS  PubMed  Google Scholar 

  29. Sersa G, Cemazar M, Parkins CS, Chaplin DJ. Tumour blood flow changes induced by application of electric pulses. Eur J Cancer. 1999;35:672– 7

    Article  CAS  PubMed  Google Scholar 

  30. Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res. 2000;6:863– 7

    CAS  PubMed  Google Scholar 

  31. Sersa G. The state-of-the-art of electrochemotherapy before the ESOPE study: advantages and clinical uses. EJC Suppl. 2006;4:52– 9

    Google Scholar 

  32. Sersa G, Cemazar M, Miklavcic D, Rudolf Z. Electrochemo-therapy of tumours. Radiol Oncol. 2006;40:163– 74

    CAS  Google Scholar 

  33. Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, Miklavcic D, Kadivec M, Kranjc S, Secerov A, Cemazar M. Vascular disrupting action of electroporation and electro-chemotherapy with bleomycin in murine sarcoma. Brit J Cancer. 2008;98:388– 98

    Article  CAS  PubMed  Google Scholar 

  34. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M. Electrochemotherapy in treatment of tumours. EJSO. 2008;34:232– 40

    CAS  PubMed  Google Scholar 

  35. Snoj M, Rudolf Z, Cemazar M, Jancar B, Sersa G. Successful sphincter-saving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy. AntiCancer Drugs. 2005; 16:345– 8

    Article  CAS  PubMed  Google Scholar 

  36. Snoj M, Rudolf Z, Paulin-Kosir S, Cemazar M, Snoj R, Sersa G. Long lasting complete response in melanoma treated by electrochemotherapy. EJC Suppl. 2006;4: 26– 8

    Google Scholar 

  37. Snoj M, Cemazar M, Slekovec Kolar B, Sersa G. Effective treatment of multiple unresectable skin melanoma metastases by electrochemotherapy: case report. Croat Med J. 2007;48:391– 5

    PubMed  Google Scholar 

Download references

Acknowledgments

The author gratefully acknowledges finan-cial support from the state budget of the Slovenian Research Agency and the European Commission' s ESOPE project (QLK-2002– 02003), funded under the 5th Framework Program

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gregor Sersa .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sersa, G. (2010). Electrochemotherapy in Treatment of Cutaneous Tumors. In: Jemec, G.B.E., Kemeny, L., Miech, D. (eds) Non-Surgical Treatment of Keratinocyte Skin Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79341-0_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-79341-0_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-79340-3

  • Online ISBN: 978-3-540-79341-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics